ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024)

ClearPoint Neuro's (CLPT) quarterly Notes Payables came in at $10.0 million in Q2 2024, little changed quarter-over-quarter from $10.0 million in Q1 2024.

ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024) Analysis & Trends

ClearPoint Neuro has disclosed Notes Payables across 9 years of filings, most recently posting $10.0 million for Q2 2024.

  • Notes Payables for Q2 2024 came in at $10.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $10.0 million (changed N/A YoY), and the FY2017 annual result was $1.8 million, down 11.44% from the prior year.
  • Notes Payables came in at $10.0 million for Q2 2024 at ClearPoint Neuro, roughly flat from $10.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $10.0 million in Q2 2024 to a low of $10.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 9.98 Mn
Mar 31, 2024 9.96 Mn
Jun 30, 2018 2.03 Mn
Mar 31, 2018 1.94 Mn
Dec 31, 2017 1.80 Mn
Dec 31, 2016 2.03 Mn
Sep 30, 2016 1.25 Mn
Jun 30, 2016 3.60 Mn
Mar 31, 2016 1.09 Mn
Sep 30, 2015 933,994.00
Jun 30, 2015 4.68 Mn
Mar 31, 2015 4.56 Mn
Dec 31, 2014 754,328.00
Mar 31, 2014 3.31 Mn
Dec 31, 2013 4.34 Mn
Sep 30, 2013 217,560.00
Jun 30, 2013 3.78 Mn
Mar 31, 2013 202,886.00
Dec 31, 2012 2.00 Mn
Sep 30, 2012 191,023.00